626 search results for “effective drug development” in the Staff website
-
From discovery to business: 'In the lab, we often don't realise that we are working to help an immense number of patients'
'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge. With their company Iprotics, they want to develop a drug that can better treat patients with autoimmune diseases and blood cancers. 25,000 euros of prize…
-
Developing drugs with artificial intelligence
Developing new drugs is a difficult process. With the aid of artificial intelligence, Pharmaceutical scientist Xuhan Liu has developed methods that can help make drug design cheaper and faster. PhD defence on 15 February.
-
Kick Moors
Bestuursbureau
c.c.moors@bb.leidenuniv.nl | +31 71 527 2727
-
Hildert Bronkhorst
Science
h.bronkhorst@biology.leidenuniv.nl | +31 71 527 4964
-
Eline Dekeyster
Faculteit der Sociale Wetenschappen
e.a.g.dekeyster@fsw.leidenuniv.nl | +31 71 527 2727
-
Alexander Kros
Science
a.kros@chem.leidenuniv.nl | +31 71 527 4234
-
Accelerator launched: patients at the centre of innovative cancer drug development
Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, thus ensuring the patient is at the heart of the process.
-
Eveline Crone
Faculteit der Sociale Wetenschappen
ecrone@fsw.leidenuniv.nl | +31 71 527 2727
-
resilience: Individual differences in genetic and environmental effects on brain development
PhD defence
-
Sofie Rasmussen
Science
a.s.b.rasmussen@cml.leidenuniv.nl | +31 71 527 2727
-
New potential drug suppresses chemotherapy induced neuropathic pain
Oncode Investigator Mario van der Stelt and his colleagues have discovered a new potential drug that suppresses chemotherapy induced neuropathic pain.
-
NIAS grant for research on ‘War on Drugs’
His article on ‘the War on Drugs’ in Colombia and the Philippines has been in the top five most downloaded articles of Oxford University Press for some time. Now, Assistant Professor Santino Regilme is to receive a NIAS grant to map out the global war on drugs.
-
Peter Bouwman
Science
r.j.p.bouwman@lacdr.leidenuniv.nl | +31 71 527 6105
-
Channeke Keuls
Faculteit der Sociale Wetenschappen
c.s.keuls@fsw.leidenuniv.nl | +31 71 527 2727
-
Artificial intelligence as the co-pilot for drug discovery
There are more molecules that could conceivably be candidate drugs than there are stars in the universe. How can we ever efficiently identify those molecules? Professor of AI and Medicinal Chemistry, Gerard van Westen: ‘I’m going to use artificial intelligence as the co-pilot to make an automated search.’…
-
invests many millions in faster and more sustainable (cancer) drug development
On 14 April, the National Growth Fund awarded million euros in grants to two consortia in which Leiden's science faculty is involved. Pharma-NL will receive 80 million euros and Oncode-PACT 325 million euros. Pharma-NL wants to make medicines available to the patient faster and more sustainably. Oncode-PACT…
-
Yiran Yang
Faculty Governance and Global Affairs
y.yang@luc.leidenuniv.nl | +31 71 527 5163
-
Camila Espinoza Chaparro
Faculteit der Sociale Wetenschappen
c.p.espinoza.chaparro@fsw.leidenuniv.nl | +31 71 527 6718
-
Martijn Defilet
Faculteit Archeologie
m.p.defilet@arch.leidenuniv.nl | +31 71 527 2727
-
Mi-Lan Woudstra
Faculteit der Sociale Wetenschappen
m.j.woudstra@fsw.leidenuniv.nl | +31 71 527 5439
-
Ymke de Bruijn
Faculty Governance and Global Affairs
y.de.bruijn@fgga.leidenuniv.nl | +31 70 800 9503
-
David Ehrhardt
Faculty Governance and Global Affairs
d.w.l.ehrhardt@luc.leidenuniv.nl | +31 70 800 9313
-
Marcella Pavias
Faculteit der Sociale Wetenschappen
m.pavias.2@fsw.leidenuniv.nl | +31 71 527 4895
-
Giulia Callegaro
Science
g.callegaro@lacdr.leidenuniv.nl | +31 71 527 6105
-
How to develop cancer drugs with less side effects
Lecture, Tuesday Talks: Science Insights
-
Anneke Both-de Vries
Faculteit der Sociale Wetenschappen
bothanna@fsw.leidenuniv.nl | +31 71 527 4834
-
THNK – A science-based checklist for effective science communication
Lecture
-
Standing up for yourself, while keeping good relations (Effective communication)
Communication, Working effectively
-
Linda van Leijenhorst
Faculteit der Sociale Wetenschappen
lleijenhorst@fsw.leidenuniv.nl | +31 71 527 3750
-
Stefanie van Esveld
Faculty Governance and Global Affairs
s.van.esveld@fgga.leidenuniv.nl | +31 70 800 9500
-
Eduard Klapwijk
Faculteit der Sociale Wetenschappen
e.t.klapwijk@fsw.leidenuniv.nl | +31 71 527 2727
-
Harriet Vermeer
Faculteit der Sociale Wetenschappen
vermeer@fsw.leidenuniv.nl | +31 71 527 3491
-
Solutions and Universiteit Leiden Announce Collaboration to Develop Advanced Polyaminoacid Drug Delivery Systems
Polypeptide Therapeutic Solutions (PTS), a leader in the design, development and custom manufacturing of polyamino-acid based delivery systems for therapeutic drugs and the Leiden Academic Centre for Drug Research (LACDR) today announced a research collaboration to develop advanced drug delivery systems…
-
Ine Alberts
Bestuursbureau
j.b.p.m.alberts@bb.leidenuniv.nl | +31 71 527 4188
-
Tineke Rutgers
Bestuursbureau
t.rutgers@bb.leidenuniv.nl | +31 71 527 7891
-
Bob van de Water
Science
water_b@lacdr.leidenuniv.nl | +31 71 527 6223
-
Maedeh Nasri
Faculteit der Sociale Wetenschappen
m.nasri@fsw.leidenuniv.nl | +31 71 527 2727
-
Susanne Kamerling
Faculty Governance and Global Affairs
s.kamerling@fgga.leidenuniv.nl | +31 70 800 9506
-
Caroline Archambault
Faculty Governance and Global Affairs
c.archambault@luc.leidenuniv.nl | +31 70 800 9963
-
Psychologist writes sober book about psychedelic drugs
Psychedelic drugs like magic mushrooms and LSD are embraced by some and seen as lethal by others. Cognitive psychologist Michiel van Elk delved into the world of psychedelic drugs and wrote a surprisingly sober book about them. ‘Without first-hand experience my story wouldn’t be complete.’
-
Key for effective application of a new revolutionary cholesterol lowering drug resides in a 30 year old Leiden Patent
‘’ And then the world changed forever ,welcome to the future’’. These are the words that Kausik Ray (President of the European Atherosclerosis Society) spoke when the worldwide first dose of inclisiran, a novel SiRNA based cholesterol lowering agent, was administered at the Cardiology lipid clinic at…
-
LACDR PhD Introductory course on Drug Research
Recently, we had the LACDR PhD Introductory course on Drug Research for starting PhD candidates. It was great to have this live event live in castle Oud Poelgeest, after two years of restrictions.
-
LACDR PhD Introductory course on Drug Research
This week, we had the LACDR PhD Introductory course on Drug. This is always a great opportunity for starting PhD candidates to get to know LACDR, CHDR, the Clinical Pharmacology department of LUMC and the embedding of the institute in the BioSciencepark as a whole.
-
PhD Introductory Course on Drug Research
At the end of February, we had the PhD Introductory Course on Drug Research for starting PhD candidates from LACDR. This 3-days event took place at Castle Oud Poelgeest, a great location to be completely out of the work environment. We welcomed 30 PhD candidates, with whom we had an inspiring and…
-
LACDR PhD introductory course on drug research
Due to the corona pandemic and the uncertainty of the circumstances end of January 2022, is decided to postpone the LACDR PhD introductory course.
-
Laura Heitman
Science
l.h.heitman@lacdr.leidenuniv.nl | +31 71 527 4558
-
LACDR PhD Introductory course on Drug Research
The PhD introductory course will take place on 30 May, 31 May and 1 June 2022 in castle Oud Poelgeest. We are very happy that it will be a live event (as it stands now).
-
Janne van Doorn
Faculteit Rechtsgeleerdheid
a.j.van.doorn@law.leidenuniv.nl | +31 71 527 1972
-
Aleksandrina Skvortsova
Faculteit der Sociale Wetenschappen
a.skvortsova@fsw.leidenuniv.nl | +31 71 527 2727
-
Countering nerve pain caused by chemotherapy with new drug
Nerve pain is one of the most common side effects of chemotherapy. It is therefore one of the biggest reasons for cancer patients to stop treatment early. Darcy Reynolds worked on new drug candidates against this pain during her bachelor's thesis. She developed a new series of molecules that increase…